The results indicate that pharmacological blocking of CCR5 only exerted limited effect on the pathophysiology of PM and therefore CCR5-mediated activation may not be necessarily essential for defense against pneumococcal infection. This evidence concerns the gene CCR5 and pneumococcal infection.